{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:55:02Z","timestamp":1771905302966,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Management of patients with oncohaematological disorders such as monoclonal gammopathy of undetermined significance (MGUS) is a frequent problem in pre-transplant work-up. Insights on disease progression and long-term functional outcomes are still lacking in this setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective analysis on all patients with MGUS who underwent kidney transplant (KT) at our centre between 1 January 2000 and 31 December 2017 (cases, n\u2009=\u200965). Patients were matched with a control group (KTs with similar characteristics but without history of haematological disease, controls, n\u2009=\u20091079). Primary endpoints were graft and patient survival; secondary endpoints were causes of graft failure, patient death, occurrence of allograft rejection, post-transplant neoplasia (not correlated to previous disorder) and\/or infectious episodes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The MGUS and control groups had a similar mean age [60 (29\u201379) versus 55.2 (19.3\u201379.5) years, respectively] and percentage of males (69.2% versus 64.6%, respectively). Median follow-up time since KT was 3.5\u2009years (0\u201314) in cases and 8.3\u2009years (0\u201314.9) in controls. All MGUS patients underwent KT following extensive multidiscliplinary investigations. No differences were found between cases and controls regarding patient and graft survival or post-transplant complications except for lower incidence of infections (58.7% versus 69.8%, P\u2009=\u20090.019) and increased use of mTOR inhbitors (30.3% versus 14.7%, P\u2009=\u20090.001) in MGUS. MGUS isotype did not influence graft and patient survival. The absence of difference in patients and graft survival was also confirmed in an adjunctive analysis where MGUS were compared with controls (ratio 1:2) matched for recipient age, gender, number of transplantations and transplant period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with MGUS may undergo KT without significantly increased risks of complications, provided that appropriate diagnostic procedures are carefully followed. Multidiscipline-based studies are crucial for establishing well designed pre- and post-transplant protocols for the best management of patients with coexisting MGUS and end-stage renal disease.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ckj\/sfaa105","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T11:13:20Z","timestamp":1588936400000},"page":"317-324","source":"Crossref","is-referenced-by-count":8,"title":["Monoclonal gammopathy of undetermined significance coexisting in patients undergoing kidney transplantation does not adversely influence post-graft clinical outcome"],"prefix":"10.1093","volume":"14","author":[{"given":"Roberta","family":"Clari","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Division of Nephrology Dialysis and Transplantation, Renal Transplantation Center \u2018A. Vercellone\u2019, Citt\u00e0 della Salute e della Scienza Hospital and University of Turin, Turin, Italy"},{"name":"Nephrology Unit, ASL TO5, Chieri, TO, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Tarella","sequence":"additional","affiliation":[{"name":"Hemato-Oncology Div., IEO, European Institute of Oncology IRCCS, Milan and Dip. Scienze Salute, University of Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Giraudi","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Division of Nephrology Dialysis and Transplantation, Renal Transplantation Center \u2018A. Vercellone\u2019, Citt\u00e0 della Salute e della Scienza Hospital and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Torazza","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Division of Nephrology Dialysis and Transplantation, Renal Transplantation Center \u2018A. Vercellone\u2019, Citt\u00e0 della Salute e della Scienza Hospital and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Gallo","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Division of Nephrology Dialysis and Transplantation, Renal Transplantation Center \u2018A. Vercellone\u2019, Citt\u00e0 della Salute e della Scienza Hospital and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lavacca","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Division of Nephrology Dialysis and Transplantation, Renal Transplantation Center \u2018A. Vercellone\u2019, Citt\u00e0 della Salute e della Scienza Hospital and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Fop","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Division of Nephrology Dialysis and Transplantation, Renal Transplantation Center \u2018A. Vercellone\u2019, Citt\u00e0 della Salute e della Scienza Hospital and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Mella","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Division of Nephrology Dialysis and Transplantation, Renal Transplantation Center \u2018A. Vercellone\u2019, Citt\u00e0 della Salute e della Scienza Hospital and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Dolla","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Division of Nephrology Dialysis and Transplantation, Renal Transplantation Center \u2018A. Vercellone\u2019, Citt\u00e0 della Salute e della Scienza Hospital and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Biancone","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Division of Nephrology Dialysis and Transplantation, Renal Transplantation Center \u2018A. Vercellone\u2019, Citt\u00e0 della Salute e della Scienza Hospital and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"2021020321155255900_sfaa105-B1","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2018.01.002","article-title":"US Renal Data System 2017 annual data report: epidemiology of kidney disease in the United States","volume":"71","author":"Saran","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2021020321155255900_sfaa105-B2","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(00)02298-4","article-title":"Cancer risk in patients on dialysis and after renal transplantation","volume":"355","author":"Birkeland","year":"2000","journal-title":"Lancet"},{"key":"2021020321155255900_sfaa105-B3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000337482","article-title":"Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation","volume":"35","author":"Naina","year":"2012","journal-title":"Am J Nephrol"},{"key":"2021020321155255900_sfaa105-B4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1399-0012.2011.01539.x","article-title":"Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy","volume":"26","author":"Soltero","year":"2012","journal-title":"Clin Transplant"},{"key":"2021020321155255900_sfaa105-B5","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.transproceed.2015.08.023","article-title":"Outcomes of monoclonal gammopathy of undetermined significance in patients who underwent kidney transplantation","volume":"47","author":"Bancu","year":"2015","journal-title":"Transplant Proc"},{"key":"2021020321155255900_sfaa105-B6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0272-6386(99)70125-3","article-title":"Benign monoclonal gammopathy turning to AL amyloidosis after kidney transplantation","volume":"34","author":"Dysseleer","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2021020321155255900_sfaa105-B7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/nep.12068","article-title":"KHA-CARI guideline: recipient assessment for transplantation","volume":"18","author":"Campbell","year":"2013","journal-title":"Nephrology"},{"key":"2021020321155255900_sfaa105-B8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1503\/cmaj.051291","article-title":"Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation","volume":"173","author":"Knoll","year":"2005","journal-title":"CMAJ"},{"key":"2021020321155255900_sfaa105-B9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"2021020321155255900_sfaa105-B10","first-page":"ii1","article-title":"European Renal Best Practice. ERBP guideline on kidney donor and recipient evaluation and perioperative care","volume":"28","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2021020321155255900_sfaa105-B11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.V11suppl_1s1","article-title":"Recommendations for the outpatient surveillance of renal transplant recipients","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2021020321155255900_sfaa105-B12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000328070","article-title":"Renal association clinical practice guideline on the assessment of the potential kidney transplant recipient","volume":"118","author":"Dudley","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"2021020321155255900_sfaa105-B13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"Br J Haematol"},{"key":"2021020321155255900_sfaa105-B14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance. Natural history in 241 cases","volume":"64","author":"Kyle","year":"1978","journal-title":"Am J Med"},{"key":"2021020321155255900_sfaa105-B15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4065\/79.7.859","article-title":"Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later","volume":"79","author":"Kyle","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"2021020321155255900_sfaa105-B16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jamaoncol.2019.1568","article-title":"Association of immune marker changes with progression of monoclonal gammopathy of undetermined significance to multiple myeloma","volume":"5","author":"Landgren","year":"2019","journal-title":"JAMA Oncol"},{"key":"2021020321155255900_sfaa105-B17","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"2021020321155255900_sfaa105-B18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2021020321155255900_sfaa105-B19","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11255-017-1594-y","article-title":"Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity","volume":"49","author":"Ciocchini","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"2021020321155255900_sfaa105-B20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ki.2008.577","article-title":"Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits","volume":"75","author":"Czarnecki","year":"2009","journal-title":"Kidney Int"},{"key":"2021020321155255900_sfaa105-B21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-term outcome of renal transplantation in light-chain deposition disease","volume":"43","author":"Leung","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2021020321155255900_sfaa105-B22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2215\/CJN.05750710","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021020321155255900_sfaa105-B23","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1681\/ASN.2013070715","article-title":"Clinical findings, pathology, and outcomes of C3GN after kidney transplantation","volume":"25","author":"Zand","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2021020321155255900_sfaa105-B24","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/oxfordjournals.ndt.a027215","article-title":"Monoclonal gammopathy after intense induction immunosuppression in renal transplant patients","volume":"11","author":"Passweg","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"2021020321155255900_sfaa105-B25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.transproceed.2014.11.021","article-title":"Follow-up monoclonal gammopathy of undetermined significance in kidney transplant","volume":"47","author":"Cu\u00e9llar-Garcia C, Ruiz-Mateos","year":"2015","journal-title":"Transplant Proc"},{"key":"2021020321155255900_sfaa105-B26","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1097\/TP.0000000000001884","article-title":"Monoclonal gammopathy of undetermined significance after kidney transplantation: single-center experience","volume":"101","author":"Alfano","year":"2017","journal-title":"Transplantation"},{"key":"2021020321155255900_sfaa105-B27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000001447","article-title":"Cancer and mTOR inhibitors in transplant recipients","volume":"101","author":"De Fijter","year":"2017","journal-title":"Transplantation"},{"key":"2021020321155255900_sfaa105-B28","doi-asserted-by":"crossref","first-page":"e0194975","DOI":"10.1371\/journal.pone.0194975","article-title":"Effects of mtor-is on malignancy and survival following renal transplantation: a systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months","volume":"13","author":"Wolf","year":"2018","journal-title":"PLoS One"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/14\/1\/317\/36184805\/sfaa105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/14\/1\/317\/36184805\/sfaa105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T09:11:28Z","timestamp":1666516288000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/14\/1\/317\/5908056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,9,18]]},"published-print":{"date-parts":[[2021,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaa105","relation":{},"ISSN":["2048-8513"],"issn-type":[{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,9,18]]}}}